Literature DB >> 11670202

Rhenium(V) and Technetium(V) Oxo Complexes of an N(2)N'S Peptidic Chelator: Evidence of Interconversion between the Syn and Anti Conformations.

Ernest Wong1, Theresa Fauconnier, Samantha Bennett, John Valliant, Tam Nguyen, Frank Lau, Linda F. L. Lu, Alfred Pollak, Russell A. Bell, John R. Thornback.   

Abstract

Neutral Re(V) and Tc(V) oxo complexes of the peptide dimethylglycyl-L-seryl-L-cysteinylglycinamide (RP294) were prepared and characterized by HPLC, spectroscopic techniques, and X-ray crystallographic analysis. The peptide was prepared as a single peptide chain using solid phase methods and characterized by HPLC and various spectroscopic techniques. The water-soluble Re(V) oxo complex of dimethylglycyl-L-seryl-L-cysteinylglycinamide [ReO(RP294)] was prepared from the reaction of the peptide with either [ReO(2)(en)(2)]Cl or ReOCl(3)(PPh(3))(2) in the presence of base. The complex exists as two isomers, the serine CH(2)OH group being in the syn oranti conformation with respect to the Re-oxo bond. The ratio of the isomers at room temperature is 1:1.1. The isomers were separated by reverse-phase HPLC, but the isolation of each isomer was complicated by their rapid interconversion in aqueous solution at room temperature. The molecular structure of the syn isomer of the Re complex was determined by X-ray crystallography. Crystals of syn-[ReO(RP294)] (C(12)H(20)N(6)O(5)ReS) are orthorhombic, of space group P2(1)2(1)2(1), with a = 6.954(1) Å, b = 8.0472(1) Å, c = 32.9183(4) Å, and Z = 4. The structure was solved by direct methods and was refined by full-matrix least-squares procedures to R = 0.0327 (R(w) = 0.0838) for 10 447 reflections with I > 2sigma(I). The Re metal was coordinated in a distorted square pyramidal geometry with the oxo moiety in the apical position. The peptide coordinated to ReO(3+) via the N(amine) atom of dimethylglycine, the S(thiolate) atom of cysteine, and the two N(amide) atoms of serine and cysteine (an N(2)N'S donor atom set). The Re atom lies approximately 0.74 Å above the distorted plane formed by the N(2)N'S donor atom set. Variable-pH (1)H NMR spectral data showed the Re complex was stable from pH 5 to 8.5. The reaction of (99)TcO(4)(-) with SnCl(2), sodium gluconate, and RP294 produced the (99)Tc(V) oxo RP294 complex, [(99)TcO(RP294)]. Like the [ReO(RP294)] complex, [(99)TcO(RP294)] also exists in the syn and anti conformations in a ratio of approximately 1:1. The (99m)Tc complex of RP294 was prepared at the tracer level from the reaction of Na[(99m)TcO(4)] with excess SnCl(2), sodium gluconate, and RP294. The (99m)Tc and Re RP294 complexes behaved similarly under identical HPLC conditions.

Entities:  

Year:  1997        PMID: 11670202     DOI: 10.1021/ic9706562

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  8 in total

1.  Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo.

Authors:  Gopal Pathuri; Andria F Hedrick; Bryan C Disch; John T Doan; Michael A Ihnat; Vibhudutta Awasthi; Hariprasad Gali
Journal:  Bioconjug Chem       Date:  2011-12-20       Impact factor: 4.774

Review 2.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

3.  Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides.

Authors:  Vanessa A Sanders; David Iskhakov; Dalya Abdel-Atti; Matthew Devany; Michelle C Neary; Ken R Czerwinski; Lynn C Francesconi
Journal:  Nucl Med Biol       Date:  2018-11-12       Impact factor: 2.408

4.  The syntheses and structures of '3+2' and '2+2+1' oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N,O donor ligand.

Authors:  Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-10-20       Impact factor: 2.545

5.  Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.

Authors:  Irene Tsiapa; George Loudos; Eirini A Fragogeorgi; Penelope Bouziotis; Dimitrios Psimadas; Stavros Xanthopoulos; Maria Paravatou-Petsotas; Lazaros Palamaris; Alexandra D Varvarigou; Dimitris Karnabatidis; George C Kagadis
Journal:  Cancer Biother Radiopharm       Date:  2014-12       Impact factor: 3.099

Review 6.  Bifunctional chelators for radiorhenium: past, present and future outlook.

Authors:  Diana R Melis; Andrew R Burgoyne; Maarten Ooms; Gilles Gasser
Journal:  RSC Med Chem       Date:  2022-01-14

7.  Isolation, characterization, and biological evaluation of syn and anti diastereomers of [(99m)Tc]technetium depreotide: a somatostatin receptor binding tumor imaging agent.

Authors:  John E Cyr; Daniel A Pearson; Carol A Nelson; Barbara A Lyons; Yongyong Zheng; Judit Bartis; Jiafang He; Melchor V Cantorias; Robertha C Howell; Lynn C Francesconi
Journal:  J Med Chem       Date:  2007-08-11       Impact factor: 7.446

8.  MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals.

Authors:  Melchor V Cantorias; Robertha C Howell; Louis Todaro; John E Cyr; Dietmar Berndorff; Robin D Rogers; Lynn C Francesconi
Journal:  Inorg Chem       Date:  2007-08-11       Impact factor: 5.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.